Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atanu Bhattacharjee

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2025
Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptomsFraser Paterson, Jing Yuan On, Dania Ahmed, et al.
Oral Oncology|January 13, 2015
A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neckVijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
South Asian Journal of Cancer|February 7, 2018
EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burdenAmit Joshi, Vijay M Patil, Vanita Noronha, et al.
Cancer Medicine|March 28, 2022
Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatinNandini S Menon, Vanita Noronha, Vijay Maruti Patil, et al.
Respiratory Medicine|May 29, 2025
Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthmaMarcello Cottini, Remo Poto, Atanu Bhattacharjee, et al.
South Asian Journal of Cancer|November 16, 2018
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patientsVijay Patil, Amit Joshi, Vanita Noronha, et al.
Progress in Cardiovascular Diseases|October 1, 2023
Self-reported walking pace and 10-year cause-specific mortality: A UK biobank investigationJonathan Goldney, Paddy C Dempsey, Joseph Henson, et al.
Oral Oncology|December 12, 2017
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancerAmit Joshi, Vijay Patil, Vanita Noronha, et al.
Oral Oncology|December 13, 2016
Expectations and preferences for palliative chemotherapy in head and neck cancers patientsVijay Patil, Amit Joshi, Vanita Noronha, et al.
Frontiers in Oncology|April 5, 2018
Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma CellsChakrabhavi Dhananjaya Mohan, Nirvanappa C Anilkumar, Shobith Rangappa, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2025
Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptomsFraser Paterson, Jing Yuan On, Dania Ahmed, et al.
Oral Oncology|January 13, 2015
A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neckVijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
South Asian Journal of Cancer|February 7, 2018
EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burdenAmit Joshi, Vijay M Patil, Vanita Noronha, et al.
Cancer Medicine|March 28, 2022
Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatinNandini S Menon, Vanita Noronha, Vijay Maruti Patil, et al.
Respiratory Medicine|May 29, 2025
Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthmaMarcello Cottini, Remo Poto, Atanu Bhattacharjee, et al.
South Asian Journal of Cancer|November 16, 2018
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patientsVijay Patil, Amit Joshi, Vanita Noronha, et al.
Progress in Cardiovascular Diseases|October 1, 2023
Self-reported walking pace and 10-year cause-specific mortality: A UK biobank investigationJonathan Goldney, Paddy C Dempsey, Joseph Henson, et al.
Oral Oncology|December 12, 2017
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancerAmit Joshi, Vijay Patil, Vanita Noronha, et al.
Oral Oncology|December 13, 2016
Expectations and preferences for palliative chemotherapy in head and neck cancers patientsVijay Patil, Amit Joshi, Vanita Noronha, et al.
Frontiers in Oncology|April 5, 2018
Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma CellsChakrabhavi Dhananjaya Mohan, Nirvanappa C Anilkumar, Shobith Rangappa, et al.
Pageof 16